Site-Overview.com
 

Analysis of websites containing pfizeroncologytogether.com backlinks

These websites are/were linking to pfizeroncologytogether.com.

 
Websites found: 5
Number of websited displayed: 5
 

List of results:

RCC Treatment | INLYTA® (axitinib) Tablets | Safety Info
http://site-overview.com/stats/inlyta.com
Learn about INLYTA® (axitinib) Tablets for the treatment of advanced kidney cancer or advanced renal cell carcinoma (RCC). See risks and benefits.
  • Google Analytics ID: 60040448-1
  • Website Address renewal date: 16/7/22
  • Domain Address Reg. date: 01/8/22
  • Website address in use until: 18/8/22
Patient Support & Financial Assistance | Pfizer Oncology Together
http://site-overview.com/stats/pfizeroncologytogether.com
  • Website Address renewal date: 17/2/1
  • Domain Address Reg. date: 17/2/1
  • Website address in use until: 19/2/1
XALKORI® (crizotinib) For ALK+ or ROS1+ mNSCLC Treatment | Safety Info
http://site-overview.com/stats/xalkori.com
Learn about Rx XALKORI® (crizotinib) for treatment of ALK+ or ROS1+ non-small cell lung cancer that has spread to other parts of the body. See risks & benefits.
  • Website Address renewal date: 16/5/23
  • Domain Address Reg. date: 10/6/23
  • Website address in use until: 18/6/23
BOSULIF® (bosutinib) Tablets | Safety Info | BOSULIF® (bosutinib) Tablets
http://site-overview.com/stats/bosulif.com
Visit the official website for BOSULIF® (bosutinib) Tablets. Learn about the risks & benefits of BOSULIF.
  • Google Analytics ID: 60063590-1
  • Website Address renewal date: 16/6/7
  • Domain Address Reg. date: 10/7/8
  • Website address in use until: 18/7/8
RCC | GIST | PNET | SUTENT® (sunitinib malate) Safety Info
http://site-overview.com/stats/sutent.com
Learn about SUTENT® (sunitinib malate) for the treatment of advanced kidney cancer (RCC), GIST, and advanced pancreatic NET. See risks and benefits.
  • Google Analytics ID: 60148791-1
  • Website Address renewal date: 16/2/10
  • Domain Address Reg. date: 04/3/12
  • Website address in use until: 18/3/12
2024-05-25 10:48:02 ... 0.0105